Skip to main content

Table 2 Treatment and follow-up data in WCH cohort

From: Expression of FSCN1 and FOXM1 are associated with poor prognosis of adrenocortical carcinoma patients

Characteristics

Number (%)

Surgery type

 Open

34 (66.7)

 laparoscopic

17 (33.3)

Re-operation on recurrence cases

9 (17.6)

Mitotane

4 (7.8)

Other (radiation, radiofrequency ablation, other chemotherapies)

4 (7.8)

Margin status (R1/2/X)

13 (25.5)

Duration of follow up – days (median, range)

723 (117–3210)

Survival status (during follow up)

 Recurrences

24 (47.06)

 Deaths

33 (64.71)